Mechanisms of Yiqi Huoxue Granule in Atherosclerosis Treatment: Insights from UPLC-Q-Exactive Orbitrap-MS Analysis, Network Pharmacology, Molecular Docking, and Experimental Verification
Journal of Inflammation Research · 2026-01 · Volume 19 · 1-22
DOI: 10.2147/jir.s566368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-01. Verfasst von Xinzhou Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Second Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, 450002, People's Republic of China. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, 450002, People's Republic of China.
- Graduate School, Henan University of Chinese Medicine, Zhengzhou, 450046, People's Republic of China.
- Institute of Cardiovascular Disease, Henan University of Chinese Medicine, Zhengzhou, 450002, People's Republic of China.
ORCID-Profile: Zehao Lei
Zitieren
APA
Wang, X., Liu, S., Lei, Z., Cao, P., Shi, W., Gao, S., & Wu, H. (2026). Mechanisms of Yiqi Huoxue Granule in Atherosclerosis Treatment: Insights from UPLC-Q-Exactive Orbitrap-MS Analysis, Network Pharmacology, Molecular Docking, and Experimental Verification. Journal of Inflammation Research, Volume 19, 1-22. https://doi.org/10.2147/jir.s566368
Vancouver
Wang X, Liu S, Lei Z, Cao P, Shi W, Gao S, et al. Mechanisms of Yiqi Huoxue Granule in Atherosclerosis Treatment: Insights from UPLC-Q-Exactive Orbitrap-MS Analysis, Network Pharmacology, Molecular Docking, and Experimental Verification. Journal of Inflammation Research. 2026;Volume 19:1-22. doi:10.2147/jir.s566368
BibTeX
@article{Wang2026,
author = {Wang, Xinzhou and Liu, Shanshan and Lei, Zehao and Cao, Panxia and Shi, Weili and Gao, Shuibo and Wu, Hong},
title = {Mechanisms of Yiqi Huoxue Granule in Atherosclerosis Treatment: Insights from UPLC-Q-Exactive Orbitrap-MS Analysis, Network Pharmacology, Molecular Docking, and Experimental Verification},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--22},
doi = {10.2147/jir.s566368}
}
EUVIMED